|
[1]
|
Wu ZY, Chen JF, Scott SR, McGoogan JM. History of the HIV Epidemic in China. Curr HIV/AIDS Rep 2019;16(6):458 − 66. http://dx.doi.org/10.1007/s11904-019-00471-4CrossRef
|
|
[2]
|
Han MJ, Chen QF, Xu P, Shi Y. Forging ahead in the thirteenth five-year plan: a review and prospects of HIV/AIDS prevention and control in China. Chin J AIDS STD 2021;27(12):1327 − 31. http://dx.doi.org/10.13419/j.cnki.aids.2021.12.01 (In Chinese). CrossRef
|
|
[3]
|
Costa AB, Viscardi LH, Feijo M, Fontanari AMV. HIV Voluntary Counseling and Testing (VCT-HIV) effectiveness for sexual risk-reduction among key populations: a systematic review and meta-analysis. eClinicalMedicine 2022;52:101612. http://dx.doi.org/10.1016/j.eclinm.2022.101612CrossRef
|
|
[4]
|
The State Council of the People’s Republic of China. Chinese 12th Five-Year Plan for HIV/AIDS Prevention and Control. https://www.gov.cn/gongbao/content/2012/content_2084242.htm. [2023-9-20]. (In Chinese). |
|
[5]
|
Wang HX, Xu J, Zang CP. HIV/AIDS cases detection in medical institutions from 2016 to 2021 in China. Chin J AIDS STD 2023;29(2):157 − 60. http://dx.doi.org/10.13419/j.cnki.aids.2023.02.07 (In Chinese). CrossRef
|
|
[6]
|
Zhao TM, Liu HX, Bulloch G, Jiang Z, Cao ZB, Wu ZY. The influence of the COVID-19 pandemic on identifying HIV/AIDS cases in China: an interrupted time series study. Lancet Reg Health West Pac 2023;36:100755. http://dx.doi.org/10.1016/j.lanwpc.2023.100755CrossRef
|
|
[7]
|
He N. Research progress in the epidemiology of HIV/AIDS in China. China CDC Wkly 2021;3(48):1022 − 30. http://dx.doi.org/10.46234/ccdcw2021.249CrossRef
|
|
[8]
|
The National Disease Prevention and Control Bureau. New advances of HIV/AIDS prevention and control efforts in 2019. Chin J AIDS STD 2019;25(12):1205. http://dx.doi.org/10.13419/j.cnki.aids.2019.12.01 (In Chinese). CrossRef
|
|
[9]
|
Sun XD, Xiao YN, Peng ZH, Wang N. Frequent implementation of interventions may increase HIV infections among MSM in China. Sci Rep 2018;8(1):451. http://dx.doi.org/10.1038/s41598-017-18743-7CrossRef
|
|
[10]
|
Wu XS, Wu GH, Ma YM, Huang XJ, Yang YC, Cai YS, et al. The impact of COVID-19 non-pharmaceutical interventions on HIV care continuum in China: an interrupted time series analysis. Lancet Reg Health West Pac 2022;29:100569. http://dx.doi.org/10.1016/j.lanwpc.2022.100569CrossRef
|
|
[11]
|
Gleason N, Banik S, Braverman J, Coleman E. The impact of the COVID-19 pandemic on sexual behaviors: findings from a national survey in the United States. J Sex Med 2021;18(11):1851 − 62. http://dx.doi.org/10.1016/j.jsxm.2021.08.008CrossRef
|
|
[12]
|
Huang JF, Wu HC, Lin S, Lu LL, Zheng JL, Liu B, et al. Spatial-temporal analysis of HIV/AIDS and syphilis in mainland China from 2007 to 2017. J Med Virol 2022;94(7):3328 − 37. http://dx.doi.org/10.1002/jmv.27725CrossRef
|
|
[13]
|
Wang YL, Qin QQ, Ding ZW, Cai C, Guo W, Li DM, et al. Current situation of AIDS epidemic in China. Chin J AIDS STD 2017;23(4):330 − 3. http://dx.doi.org/10.13419/j.cnki.aids.2017.04.16 (In Chinese). CrossRef
|
|
[14]
|
Liu ZF, Tang XF, Liu YF, Zhang LL, Yang YH, Zheng YL, et al. HIV prevention and health poverty alleviation — Liangshan prefecture, Sichuan province, China, 2017-2020. China CDC Wkly 2021;3(48):1031 − 5. http://dx.doi.org/10.46234/ccdcw2021.250CrossRef
|
|
[15]
|
Jing FS, Ye Y, Zhou Y, Zhou HC, Xu ZZ, Lu Y, et al. Modelling the geographical spread of HIV among MSM in Guangdong, China: a metapopulation model considering the impact of pre-exposure prophylaxis. Philos Trans Roy Soc A Math Phys Eng Sci 2022;380(2214):20210126. http://dx.doi.org/10.1098/rsta.2021.0126CrossRef
|